These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27490275)

  • 1. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
    Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
    Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
    Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles.
    Kouassi AF; Kone M; Keita M; Esmel A; Megnassan E; N'Guessan YT; Frecer V; Miertus S
    Int J Mol Sci; 2015 Dec; 16(12):29744-71. PubMed ID: 26703572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
    Kumar SP; George LB; Jasrai YT; Pandya HA
    SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
    He X; Alian A; Ortiz de Montellano PR
    Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Frecer V; Megnassan E; Miertus S
    Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data.
    Kuo MR; Morbidoni HR; Alland D; Sneddon SF; Gourlie BB; Staveski MM; Leonard M; Gregory JS; Janjigian AD; Yee C; Musser JM; Kreiswirth B; Iwamoto H; Perozzo R; Jacobs WR; Sacchettini JC; Fidock DA
    J Biol Chem; 2003 Jun; 278(23):20851-9. PubMed ID: 12606558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
    Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
    Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.
    Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis.
    Stec J; Vilchèze C; Lun S; Perryman AL; Wang X; Freundlich JS; Bishai W; Jacobs WR; Kozikowski AP
    ChemMedChem; 2014 Nov; 9(11):2528-37. PubMed ID: 25165007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
    Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A
    J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.
    Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K
    IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy.
    Freundlich JS; Wang F; Tsai HC; Kuo M; Shieh HM; Anderson JW; Nkrumah LJ; Valderramos JC; Yu M; Kumar TR; Valderramos SG; Jacobs WR; Schiehser GA; Jacobus DP; Fidock DA; Sacchettini JC
    J Biol Chem; 2007 Aug; 282(35):25436-44. PubMed ID: 17567585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
    Suguna K; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
    Sharma SK; Kumar G; Kapoor M; Surolia A
    Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
    J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.
    Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.